Serratia marcescens is a Gram-negative bacillus belonging to the Enterobacteriaceae and is widely distributed in the environment. Usually it is not regarded as a pathogenic bacterium. However, this microorganism sometimes causes opportunistic infections in compromised hosts. S. marcescens is associated with respiratory tract infections, urinary tract infections, septicemia, meningitis and wound infections. 1) S. marcescens sometimes causes outbreaks in intensive care units (ICU). 2,3) A very serious problem with infectious diseases by S. marcescens is that this bacterium shows intrinsic resistance against many antimicrobial agents used for chemotherapy. 1) Furthermore, S. marcescens strains showing elevated resistance against b-lactams, 4) aminoglycosides, imipenem, 1) and fluoroquinolones 1) have been reported. Thus, treatment for S. marcescens infection with chemotherapeutic drugs is becoming more problematic. There are several mechanisms for resistance against drugs in bacteria, 1) inactivation of drugs by degradation or modification, 2) alteration of drug targets 3) emergence of a bypass that is not inhibited by drugs, 4) changes in membrane permeability for drugs, and 5) drug efflux from cells. Among these five mechanisms, drug efflux, especially multidrug efflux, is a major mechanism for multidrug resistance in bacteria. 5) Multidrug efflux pumps have been classified into five families according to similarities in amino acid sequences, protein sizes, and types of energy coupling. 6) All possible genes for multidrug efflux pumps included in the five families from E. coli have been cloned, expressed, and the corresponding pumps have been analyzed. 7) In S. marcescens, however, only several multidrug efflux pumps have been characterized. Berlanga et al. first reported active drug efflux in S. marcescens. 8) Kumar and Worobec reported fluoroquinolone efflux via an RNDtype efflux pump. 9) We cloned the sdeXY genes coding for an RND-type multidrug efflux pump SdeXY and characterized this pump. 10) Later sdeAB and sdeCDE were cloned and their corresponding pumps characterized. 11) We also reported on the gene cloning and characterization of SmfY, a MF-type multidrug efflux pump. 12) Here we cloned a gene related to resistance against ethi 516 We cloned a gene responsible for multidrug resistance from chromosomal DNA of Serratia marcescens, and determined the nucleotide sequence. We designated the gene as ssmE. The deduced amino acid sequence of SsmE showed high similarity with the small multidrug resistance (SMR)-type multidrug efflux pumps. Cells of Escherichia coli KAM32, a drug hyper-susceptible mutant, transformed with a plasmid pESM437 carrying the ssmE gene showed elevated minimum inhibitory concentrations of structurally unrelated antimicrobial agents. E. coli KAM32/pESM437 showed elevated energy dependent efflux of ethidium. Reverse transcriptase polymerase chain reaction (RT-PCR) analysis revealed that ssmE was expressed in cells of S. marcescens.
dium bromide from the chromosomal DNA of S. marcescens. We designated the gene as ssmE and characterized SsmE.
MATERIALS AND METHODS
Bacteria and Growth E. coli KAM32 (lacking acrB, ydhE, and hsd Ϫ ) 13) was used as a host. Cells were grown in L medium (1% polypepton, 0.5% yeast extract, 0.5% NaCl, pH 7) containing appropriate drugs at 37°C. S. marcescens NUSM8903 (generously provided by Dr. Yoshichika Arakawa, National Institute of Infectious Diseases, Tokyo, Japan), a clinical isolate, was grown at 30°C in L medium until the optical density at 650 nm reached 0.7.
Gene Manipulation Genes responsible for resistance to antimicrobial agents were cloned from the chromosome of S. marcescens, a clinically isolated strain NUSM8903, as reported previously. 12) We obtained 16 candidate hybrid plasmids and selected one of them, named pESM4, which conferred resistance to a wide range of antimicrobial agents in E. coli KAM32, and further characterized this plasmid. The DNA insert in plasmid pESM4 was digested with several restriction endonucleases and sub-cloned into pBR322 (a vector plasmid carrying an ampicillin resistance marker, from TaKaRa Co., Kyoto, Japan) or pUC19 (a vector plasmid carrying an ampicillin resistance marker, from TaKaRa Co., Kyoto, Japan). The resulting hybrid plasmids were introduced into E. coli KAM32 cells, and all transformants were analyzed for their susceptibilities to ethidium bromide. One of the plasmids pESM437 conferred elevated resistance to ethidium bromide and further analyzed.
The nucleotide sequence of the DNA insert in pESM437 was determined by the dideoxy chain termination method 14) using a DNA sequencer (ABI PRISM TM 310 Genetic Analyzer from Applied Biosystems Co., U.S.A.), and the data have been deposited to the DDBJ, EMBL, and GenBank nucleotide sequence databases with the accession No. AB361065. Sequence data were analyzed using GENETYX sequence analysis software (Software Development Co., Tokyo, Japan).
We cloned SMA2033-SMA2032 and SMA4462 genes (http://www.sanger.ac.uk/Projects/S_marcescens/) of S. marcescens as follows. DNA fragment containing the SMA2033-SMA2032 or SMA4462 gene(s) was amplified by the polymerase chain reaction (PCR) method using chromosomal DNA of S. marcescens NUSM8903 as template. Primers used for cloning of SMA2033-2032 were: aacagctgagataaatcgggataaatatgc (forward) and ttgaattctgagcgcagacgaaaaaaaccg (reverse). Primers used for cloning of SMA4462 were aggaattcacccgtttacgcgtcattttatc (forward, EcoRI site is present) and aaggatccacagcttattgcagacagccaaa (reverse, BamHI site is present). The amplified DNA fragment containing the SMA2033-2032 genes was ligated into SmaI sites of a vector pUC19. The amplified DNA fragment containing the SMA4462 gene was digested with EcoRI and BamHI and then ligated into the corresponding sites of a vector pUC19.
Drug Susceptibility Tests The minimal inhibitory concentrations (MICs) of various antimicrobial agents were determined in Muller-Hinton broth (Difco) using the standard two-fold dilution method according to the recommendations of the Japanese Society of Chemotherapy. 15) Antimicrobial agents used were obtained from commercial sources. Bacterial cells (10 5 cells) were inoculated and incubated in the test medium at 37°C for 24 h and the growth was examined by visual inspection.
Ethidium Bromide Accumulation Assay E. coli KAM32/pUC19 and KAM32/pESM437 were grown in L medium supplemented with 100 mg/ml ampicillin and harvested at mid-exponential phase of growth. After the cells were harvested, they were washed with modified Tanaka buffer 16) and then resuspended in the same buffer. Fluorescence intensity of ethidium bromide was measured with fluorescence spectrophotometer at excitation and emission wavelength of 500 and 580 nm, respectively. Ethidium bromide (final 10 mM) was added to the assay mixture supplemented with 20 mM lactate-TMAH. CCCP (carbonylcyanide mchlorophenylhydrazone) was added to the assay mixture to dissipate the proton-motive force (final 100 mM).
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) Analysis Total RNA was extracted by using the QIAGEN RNeasy Mini Kit (QIAGEN Inc.) from cells of S. marcescens NUSM8903 that were grown in L broth until the exponential phase of growth. For efficient RNA extraction, the cells were broken well using QIAshredder (QIAGEN Inc.) prior to the extraction of RNA. The extracted total RNA was used for RT-PCR with the QIAGEN One-
Step RT-PCR Kit (QIAGEN Inc.). Primers used for the RT-PCR are as follows; uncBRTfw (5Ј-ggagtatatcggtcaccacc-3Ј), uncBRTre (5Ј-ctgtcgacgaaaccaaccac-3Ј), sdeXRTfw (5Јaaacccaacagcaaggcgc-3Ј), sdeXRTre (5Ј-cgatttggtacagagacgtc-3Ј), ssmERTfw (5Ј-ccaccaccatgttgaaagcc-3Ј), ssmERTre (5Ј-ctgataaacgaacaccgcgg-3Ј). PCR without the reverse transcription reaction was performed to confirm no detectable DNA contamination. RT-PCR products were analyzed by 3% Agarose 21 (Nippon Gene Co.) gel electrophoresis.
RESULTS

Sequence Analysis
We obtained a hybrid plasmid pESM4 which conferred elevated MICs of several antimicrobial agents to a drug hyper-susceptible E. coli KAM32 (data not shown). We sub-cloned the DNA region in the pESM4, and obtained four hybrid plasmids, and tested their ability to confer resistance against ethidium bromide. E. coli KAM32 transformed with pESM434 or with pESM437 was able to grow in the presence of 10 mg/ml of ethidium bromide ( Fig.  1 ). We found that the two plasmids pESM434 and pESM437 possessed an overlapping DNA region. Thus, we concluded that the common DNA region was responsible for drug resistance. Since pESM437 possessed a shorter DNA insert than pESM434, we determined the nucleotide sequence of the DNA insert in pESM437. We found one complete open reading frame (ORF) in the DNA insert and designated the ORF as ssmE (serratia's small multidrug efflux pump). Judging from the deduced amino acid sequence, it seemed that SsmE consisted of 110 amino acid residues. As a result of a BLAST search, we found that SsmE showed high sequence similarity with EmrE Pae of P. aeruginosa (identity 59.1%, similarity 88.2%) 17) and with EmrE of E. coli (identity 53.6%, similarity 82.7%). 18) These EmrEs are members of the SMR family of multidrug efflux pumps. 19) Hydropathy analysis 20) revealed that SsmE possessed four hydrophobic regions (data not shown). It seems likely that these 4 hydrophobic regions span the cytoplasmic membrane. It is a characteristic of the SMR family multidrug efflux pumps that they possess four transmembrane domains.
We searched for other possible members of the SMR family of multidrug efflux pumps in S. marcescens based on its genome sequence (http://www.sanger.ac.uk/Projects/ S_marcescens/). We found three more genes coding for putative SMR family efflux pumps, and designated them as ssmD (SMA4462), ssmJ (SMA2033), and ssmK (SMA2032). It seemed that ssmJK was in an operon. Dendrogram analysis revealed that SsmD, SsmE, SsmJ and SsmK are really in the SMR family that includes EmrE and SugE of E. coli (Fig. 2) . SsmE was in a branch including EmrE of E. coli; SsmD was in a branch including SugE of E. coli; SsmJ was in a branch including YdgF of E. coli, and SsmK was in a branch including YdgE of E. coli.
Substrate Specificity of SsmE We measured the MICs of various antimicrobial agents with E. coli KAM32/pUC19 (control) and KAM32/pESM437 (carrying ssmE) ( Table 1) . We observed 4-fold, 16-fold and 16-fold increases in MICs of norfloxacin, acriflavine and ethidium bromide, respectively, in E. coli KAM32/pESM437 compared with the con- trol. We also observed reproducible 2-fold increase in the MICs of ciprofloxacin, chlorhexidine gluconate and methyl viologen in cells of E. coli KAM32/pESM437 compared with the control. It is clear from these results that acriflavine and ethidium bromide are good substrates for SsmE.
We also cloned ssmD and ssmJK from the chromosome of S. marcescens NUSM8903 by the PCR method as described under Materials and Methods. These genes were ligated to an expression vector and introduced into cells of E. coli KAM32. Although we measured the MICs of 15 antimicrobial agents with the transformants and control, we observed no changes in MICs (data not shown).
Ethidium Efflux Judging from sequence similarity with EmrE, a multidrug efflux pump, it seemed that SsmE functioned as an efflux pump. Since it seemed that ethidium was a good substrate for SsmE (Table 1) , we measured ethidium efflux activity with E. coli KAM32/pESM437. The intracellular levels of ethidium in E. coli KAM32/pESM437 (carrying ssmE) were much lower than in E. coli KAM32/pUC19 (control) under energized conditions (in the absence of CCCP, a H ϩ conductor) (Fig. 3) . After the addition of CCCP, the intracellular level of ethidium became higher and reached to the same plateau level in the two strains. These results in-dicate that SsmE is an energy-dependent efflux pump. It seems that SsmE functions as a substrate/H ϩ antiporter and extrudes substrate out of cells. Thus, it seems that antimicrobial agents are extruded from cells, and such cells escape from the toxicity of antimicrobial agents.
Expression of ssmE in S. marcescens We tested whether ssmE and sdeX 10) were expressed in cells of S. marcescens NUSM8903 by using the RT-PCR method (Fig.  4 ). We found that ssmE was expressed under laboratory growth conditions. The expression levels were comparable to that of uncB, a housekeeping gene for H ϩ -translocating ATPase involved in oxidative phosphorylation. We also detected expression of sdeX, a gene for a component of SdeXY which is a major RND-type multidrug efflux pump in S. marcescens. 10) Thus, it is likely that SsmE and SdeXY function in cells of S. marcescens NUSM8903 as multidrug efflux pumps. We also detected some expression of ssmD, ssmJ and ssmK (data not shown). Thus, it seems that SsmD, SsmJ and SsmK play some roles in S. marcescens NUSM8903.
DISCUSSION
We have been trying to elucidate the total picture of multidrug resistance systems in S. marcescens. So far, we have obtained many recombinant plasmids carrying chromosomal DNA regions conferring multidrug resistance in drug hypersusceptible host cells. 12, 21) We have characterized 6 of them 10, 12) (some of them are unpublished results). Five of the characterized genes were found to be for multidrug efflux pumps, and one was for a transcriptional activator. This implies that multidrug efflux pumps are most profoundly involved in multidrug resistance.
As described above, acriflavine and ethidium bromide 518 Vol. 31, No. 3 17) It should be pointed out that both acriflavine and ethidium bromide are good substrates for these two multidrug efflux pumps. 7, 17) There are nine Glu residues in SsmE, and one of them, Glu14, is in the putative first transmembrane domain. The Glu14 residue is conserved in the SMR family multidrug transporters. 22) It has been reported with EmrE of E. coli that Glu14 is involved in the binding of substrate. 23) Thus, it is likely that Glu14 in the SsmE is also involved in substrate binding. It is also likely that the three-dimensional structure of the substrate binding domain is similar between SsmE and EmrE. Most of the polar residues were conserved between SsmE and EmrE. Arg82 and Arg106 in EmrE were replaced with Lys in SsmE. It has been reported with EmrE that replacement of Arg82 with Lys and Arg106 with Lys gave no significant changes in its activity. 23) It has been reported that SugE and YdgE of E. coli conferred elevated MICs of some antimicrobial agents when over-expressed in drug hyper-susceptible host cells. 7, 24) It seems that SsmD and SsmK of S. marcescens are orthologs of SugE and YdgE of E. coli, respectively. However, we detected no changes in the MICs of 15 antimicrobial agents tested with SsmD and SsmK, as described above. Although we measured MICs of some other antimicrobial agents including deoxycholate which is a substrate for YdgFE, 7) we detected no changes with the SsmD and SsmK (data not shown). There are two possibilities for this discrepancy; 1) SsmD and SsmK of S. marcescens are not functional proteins, and 2) the expression levels of ssmD and ssmK in our experiment were not high enough to affect the MIC values of the antimicrobial agents tested.
